Cargando...
Insights into CD47/SIRPα axis-targeting tumor immunotherapy
During the last decade, inhibitors targeting immune checkpoint programmed death ligand 1/PD-1 and cytotoxic T-lymphocyte-associated protein 4 have been one of the most significant advances for cancer therapy in clinic. However, most of these therapies focused on stimulating the adaptive immune syste...
Gardado en:
| Publicado en: | Antib Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8157794/ https://ncbi.nlm.nih.gov/pubmed/34056543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tby006 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|